US OptionsDetailed Quotes
RIGL241220C6000
- 4.00
- 0.000.00%
15min DelayClose Dec 3 16:00 ET
0.00High0.00Low
4.00Open4.00Pre Close0 Volume1 Open Interest6.00Strike Price0.00Turnover411.11%IV-63.03%PremiumDec 20, 2024Expiry Date21.05Intrinsic Value100Multiplier17DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9842Delta0.0017Gamma1.27Leverage Ratio-0.0280Theta0.0025Rho1.25Eff Leverage0.0023Vega
Rigel Pharmaceuticals Stock Discussion
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
25.+
Go, Go, Go!!!
No comment yet